Actinomycosis: Difference between revisions
m (Robot: Changing Category:DiseaseState to Category:Disease) |
No edit summary |
||
| Line 11: | Line 11: | ||
OMIM = | | OMIM = | | ||
MedlinePlus = | | MedlinePlus = | | ||
eMedicineSubj = | eMedicineSubj = | | ||
eMedicineTopic = | eMedicineTopic = | | ||
MeshID = D000196 | | MeshID = D000196 | | ||
}} | }} | ||
Revision as of 22:07, 23 January 2012
For patient information click here
| Actinomycosis | |
 | |
|---|---|
| A patient with Actinomycosis on the right side of the face. | |
| ICD-10 | A42 |
| ICD-9 | 039 |
| DiseasesDB | 145 |
| MeSH | D000196 |
|
WikiDoc Resources for Actinomycosis |
|
Articles |
|---|
|
Most recent articles on Actinomycosis Most cited articles on Actinomycosis |
|
Media |
|
Powerpoint slides on Actinomycosis |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Actinomycosis at Clinical Trials.gov Trial results on Actinomycosis Clinical Trials on Actinomycosis at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Actinomycosis NICE Guidance on Actinomycosis
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Actinomycosis Discussion groups on Actinomycosis Patient Handouts on Actinomycosis Directions to Hospitals Treating Actinomycosis Risk calculators and risk factors for Actinomycosis
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Actinomycosis |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Actinomycosis (ak-tuh-nuh-my-KOH-sihs), is a rare infectious bacterial disease of humans generally caused by Actinomyces israelii, A. gerencseriae and Propionibacterium propionicus, though the condition is likely to be polymicrobial.[1] Characterized by the formation of painful abscesses in the mouth, lungs, or digestive organs, actinomycosis abscesses grow larger as the disease progresses, often over a period of months. In severe cases, the abscesses may penetrate the surrounding bone and muscle to the skin, where they break open and leak large amounts of pus.
Actinomycosis occurs in cattle and other animals as a disease called lumpy jaw. This name refers to the large abscesses that grow on the head and neck of the infected animal.
In 1877 pathologist Otto Bollinger described the presence of Actinomyces bovis in cattle, and shortly afterwards, James Israel discovered Actinomyces israelii in humans. In 1890 Eugen Bostroem isolated the causative organism from a culture of grain, grasses, and soil. After Bostroem's discovery there was a general misconception that actinomycosis was a mycosis that affected individuals who chewed grass or straw.
Causative organism
Actinomycosis is primarily caused by any of several members of the bacterial genus Actinomyces. These bacteria are generally anaerobes.[2] Actinomyces spp. normally live in the small spaces between the teeth and gums, causing infection only when they can multiply freely in anoxic environments. The three most common sites of infection are decayed teeth, the lungs, and the intestines.
Since Actinomyces bacteria are generally sensitive to penicillin, it is frequently used to treat actinomycosis.
Pathophysiology & Etiology
- 6 species cause disease in humans:
- A. israelii
- A. Naeslundii
- A. odontolyticus
- A. viscosus
- A. Meyeri
- A. gerencseriae
- Gram positive filamentous rod
- Sulfur Granules
- Actinomyces from within, Nocardia from without
- Generally low pathogenicity and cause disease only in the setting of antecedent tissue injury
Symptoms
- Cervicofacial Actinomycosis (55%)
- Thoracic Actinomycosis
- Lungs
- Pleura
- Mediastinum
- Chest wall (aspiration, extension of cervicofacial disease, transdiaphragmatic or retroperitoneal spread)
- Clinical picture of tuberculosis (TB) or malignancy
- Abdominal and Pelvic Actinomycosis
- Following:
- Penetrating trauma
- Gut perforation
- Surgical manipulation
- Ileocecal predilection
- Confused with:
- TB
- Ameboma
- Chronic appy
- Regional enteritis
- Carcinoma
- Intrauterine devices (IUD’s)
- Confused with:
- Following:
- Central Nervous System (CNS)
Pharmacotherapy
- In vitro susceptible to:
- Penicillin
- Chloramphenicol
- The tetracyclines
- Erythromycin
- Clindamycin
- Imipenem
- Streptomycin
- The cephalosporins
- Prolonged treatment (6-12 months)
Surgery and Device Based Therapy
- Surgery often required for disease of the chest, abdomen, pelvis, and central nervous system (CNS)
References
- ↑ Bowden GHW (1996). Actinomycosis in: Baron's Medical Microbiology (Baron S et al, eds.) (4th ed. ed.). Univ of Texas Medical Branch. (via NCBI Bookshelf) ISBN 0-9631172-1-1.
- ↑ Ryan KJ; Ray CG (editors) (2004). Sherris Medical Microbiology (4th ed. ed.). McGraw Hill. ISBN 0838585299.
External links
Acknowledgements
The content on this page was first contributed by: Dr. Steve Wiviott
Template:Bacterial diseases
Template:SIB
de:Aktinomykose
gl:Actinomicose
hr:Aktinomikoza
nl:Actinomycose
sr:Актиномикоза
fi:Aktinomykoosi
uk:Актиномікоз